CS logo
small CS logo
University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States
Public university in Chapel Hill, North Carolina
Chapel Hill, NC

About University of North Carolina at Chapel Hill


The University of North Carolina at Chapel Hill is a public research university in Chapel Hill, North Carolina. The flagship of the University of North Carolina system, it is considered a Public Ivy, or a public institution which offers an academic experience similar to that of an Ivy League university.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
University of North Carolina, Chapel Hill
429
National Institute of Allergy and Infectious Diseases (NIAID)
84
UNC Lineberger Comprehensive Cancer Center
60
Duke University
33
Bristol-Myers Squibb
28
National Cancer Institute (NCI)
28
Gilead Sciences
22
The George Washington University Biostatistics Center
21
Abbott Medical Devices
19
Children's Oncology Group
17
Janssen Research & Development, LLC
17
Total Rows: 100

Clinical Trials at University of North Carolina at Chapel Hill


During the past decade, University of North Carolina at Chapel Hill conducted 822 clinical trials. In the 10-year time frame, 822 clinical trials started and 498 clinical trials were completed, i.e. on average, 60.6% percent of trials that started reached the finish line to date. In the past 5 years, 290 clinical trials started and 232 clinical trials were completed. i.e. 80% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11511588881311311071079191107107999963632121353540409191414159597474676767672424Started TrialsCompleted Trails201520162017201820192020202120222023050100150
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment

Rows per page:

0–0 of 0

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "University of North Carolina at Chapel Hill" #1 sponsor was "University of North Carolina, Chapel Hill" with 429 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 84 trials sponsored, "UNC Lineberger Comprehensive Cancer Center" with 60 trials sponsored, "Duke University" with 33 trials sponsored and "Bristol-Myers Squibb" with 33 trials sponsored. Other sponsors include 1070 different institutions and companies that sponsored additional 490 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of North Carolina at Chapel Hill" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 76 trials as a collaborator, "National Cancer Institute (NCI)" with 73 trials as a collaborator, "University of North Carolina, Chapel Hill" with 60 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 56 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 52 trials as a collaborator. Other collaborators include 1580 different institutions and companies that were collaborators in the rest 669 trials.
Created with Highcharts 11.1.0Top Leading SponsorsUniversity of NorthCarolina, Chapel Hill:429University of NorthCarolina, Chapel Hill:429National Institute ofAllergy and InfectiousDiseases (NIAID): 84National Institute ofAllergy and InfectiousDiseases (NIAID): 84UNC LinebergerComprehensive CancerCenter: 60UNC LinebergerComprehensive CancerCenter: 60Duke University: 33Duke University: 33Bristol-Myers Squibb: 28Bristol-Myers Squibb: 28National CancerInstitute (NCI): 28National CancerInstitute (NCI): 28Gilead Sciences: 22Gilead Sciences: 22The George WashingtonUniversity BiostatisticsCenter: 21The George WashingtonUniversity BiostatisticsCenter: 21Abbott Medical Devices: 19Abbott Medical Devices: 19Children's Oncology Group: 17Children's Oncology Group: 17

Created with Highcharts 11.1.0Top CollaboratorsNational Heart, Lung,and Blood Institute(NHLBI): 76National Heart, Lung,and Blood Institute(NHLBI): 76National CancerInstitute (NCI): 73National CancerInstitute (NCI): 73University of NorthCarolina, Chapel Hill: 60University of NorthCarolina, Chapel Hill: 60National Institute ofMental Health (NIMH):56National Institute ofMental Health (NIMH):56Eunice Kennedy ShriverNational Institute ofChild Health and HumanDevelopment (NICHD):52Eunice Kennedy ShriverNational Institute ofChild Health and HumanDevelopment (NICHD):52National Institute ofDiabetes and Digestiveand Kidney Diseases(NIDDK): 44National Institute ofDiabetes and Digestiveand Kidney Diseases(NIDDK): 44National Institutes ofHealth (NIH): 35National Institutes ofHealth (NIH): 35University of North Carolina: 34University of North Carolina: 34National Institute ofAllergy and InfectiousDiseases (NIAID): 30National Institute ofAllergy and InfectiousDiseases (NIAID): 30Patient-CenteredOutcomes ResearchInstitute: 29Patient-CenteredOutcomes ResearchInstitute: 29

Clinical Trials Conditions at University of North Carolina at Chapel Hill


According to Clinical.Site data, the most researched conditions in "University of North Carolina at Chapel Hill" are "HIV Infections" (102 trials), "Cystic Fibrosis" (44 trials), "Breast Cancer" (41 trials), "Obesity" (25 trials) and "Colorectal Cancer" (22 trials). Many other conditions were trialed in "University of North Carolina at Chapel Hill" in a lesser frequency.

Clinical Trials Intervention Types at University of North Carolina at Chapel Hill


Most popular intervention types in "University of North Carolina at Chapel Hill" are "Drug" (862 trials), "Other" (259 trials), "Behavioral" (202 trials), "Device" (195 trials) and "Biological" (130 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (206 trials), "Zidovudine" (24 trials), "Paclitaxel" (19 trials), "Carboplatin" (17 trials) and "Cyclophosphamide" (16 trials). Other intervention names were less common.

Clinical Trials Genders at University of North Carolina at Chapel Hill


The vast majority of trials in "University of North Carolina at Chapel Hill" are 1448 trials for "All" genders, 203 trials for "Female" genders and 58 trials for "Male" genders.

Clinical Trials Status at University of North Carolina at Chapel Hill


Currently, there are 422 active trials in "University of North Carolina at Chapel Hill". 9 are not yet recruiting, 239 are recruiting, 151 are Active, not recruiting, and 23 are Enrolling by invitation. In total, there were 1083 completed trials in University of North Carolina at Chapel Hill, undefined suspended trials, and 150 terminated clinical trials to date.
Out of the total trials that were conducted in University of North Carolina at Chapel Hill, 168 "Phase 1" clinical trials were conducted, 431 "Phase 2" clinical trials and 340 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 62 trials, and there were also 468 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhaseNot Applicable: 468Not Applicable: 468Phase 2: 431Phase 2: 431Phase 3: 340Phase 3: 340Phase 1: 168Phase 1: 168Phase 4: 62Phase 4: 62Early Phase 1: 12Early Phase 1: 12

Created with Highcharts 11.1.0Trials StatusCompleted: 1083Completed: 1083Recruiting: 239Recruiting: 239Active, not recruiting: 151Active, not recruiting: 151Terminated: 150Terminated: 150Unknown status: 26Unknown status: 26Enrolling by invitation: 23Enrolling by invitation: 23Withdrawn: 17Withdrawn: 17Not yet recruiting: 9Not yet recruiting: 9Approved for marketing: 3Approved for marketing: 3No longer available: 3No longer available: 3

Departments of University of North Carolina at Chapel Hill


University of North Carolina at Chapel Hill has several departments that took part in Clinical trials: "University of North Carolina School of Dentistry" - 32 trials, "University of North Carolina at Chapel Hill, Department of Radiation Oncology" - 17 trials, "UNC at Chapel Hill School of Medicine - Dept. of Peds., Div. of Immunology & Infectious Diseases" - 17 trials, "University of North Carolina AIDS Clinical Trials Unit" - 7 trials, "University of North Carolina, Department of Psychiatry" - 6 trials, "UNC Center for Functional GI & Motility Disorders" - 6 trials, "University of North Carolina, Dept of Ophthalmology" - 6 trials, "UNC Children's Research Institute" - 4 trials, "UNC Center for Health Promotion and Disease Prevention" - 4 trials, "University of North Carolina at Chapel Hill, Program in Digestive Health and the Department of Gastroenterology and Hepatology" - 4 trials, "UNC Department of Family Medicine" - 3 trials, "Department of Periodontology UNC School of Dentistry" - 3 trials, "North Carolina Jaycee Burn Center" - 3 trials, "University of North Carolina Center for Inflammatory Bowel Disease" - 3 trials, "UNC Comprehensive Sickle Cell Program" - 3 trials, "UNC Center of Excellence for Eating Disorders" - 3 trials, "UNC Dermatology Clinical Trials Unit" - 3 trials, "University of North Carolina Department of Dermatology" - 2 trials, "Psychiatry And Clinical Research" - 2 trials, "University of North Carolina-Chapel Hill MS Clinic Within the Neuroscience Hospital" - 2 trials, "University of North Carolina, Division of Genetics and Metabolism" - 2 trials, "University of North Carolina Chapel Hill Physician Office Building" - 2 trials, "University of North Carolina Chapel Hill STD Clinic" - 2 trials, "North Carolina Children's and Adults Clinical Research Foundation" - 2 trials, "UNC Department of Neurology, Physicians Office Building" - 2 trials